Evidence map›Paper›PMID 41438147›Full record

ArticleFrontiers in medicine2025

Expanding the spectrum of chronic hepatitis E in kidney transplantation: first report of HEV-3ra infection and review of literature.

Emanuel F Matias, Mariana Azevedo, Susana Sampaio, Ana Teresa Pinho, Silvia Conde, Sandra Rebelo, Sérgio Santos-Silva, Maria S J Nascimento, João R Mesquita, Lurdes Santos

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emanuel F MatiasDepartment of Infectious Diseases, São João University Hospital Centre, Porto, Portugal.
Mariana AzevedoDepartment of Infectious Diseases, São João University Hospital Centre, Porto, Portugal.
Susana SampaioDepartment of Nephrology, São João University Hospital Centre, Porto, Portugal.
Ana Teresa PinhoDepartment of Nephrology, São João University Hospital Centre, Porto, Portugal.
Silvia CondeDepartment of Clinical Pathology, São João University Hospital Centre, Porto, Portugal.
Sandra RebeloDepartment of Clinical Pathology, São João University Hospital Centre, Porto, Portugal.
Sérgio Santos-SilvaSchool of Medicine and Biomedical Sciences (ICBAS) of the University of Porto, Porto, Portugal.
Maria S J NascimentoFaculty of Pharmacy of the University of Porto (FFUP), Porto, Portugal.
João R MesquitaLaboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Lurdes SantosDepartment of Infectious Diseases, São João University Hospital Centre, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic hepatitis E virus (HEV) infection is increasingly recognized as a significant cause of post-transplant hepatitis in immunosuppressed patients. Although HEV genotype 3 is the most prevalent in Europe, the clinical significance of subgenotypic diversity remains poorly defined. We report two kidney transplant recipients (KTR) diagnosed with chronic HEV infection during routine follow-up. Both patients presented with abnormal liver function tests in the absence of overt clinical symptoms. A broad-spectrum nested RT-PCR assay targeting the RNA-dependent RNA polymerase (RdRp) gene of the ORF1 region of the HEV genome was performed, followed by sequencing and phylogenetic analysis. Viral sequences detected in stool samples clustered with HEV-3c and HEV-3ra subtypes, the latter being a zoonotic variant associated with rabbits. Immunosuppressive reduction alone was insufficient for viral clearance, and both patients achieved sustained virologic response after six-month ribavirin therapy. These findings are consistent with established features of chronic HEV infection in KTR but also extend current knowledge by documenting the first case of HEV-3ra in this population. The present work underscores the importance of systematic HEV surveillance and routine molecular characterization in transplant medicine, reinforcing the need for timely initiation of antiviral therapy to prevent progression to advanced forms of liver disease.

Indexed as

chronic hepatitis EHEVimmunosuppressionkidney transplant recipientribavirin

Identifiers

PMID41438147
PMCPMC12719084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.